Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

NovoLog Mix 70/30 (70% Insulin Aspart [rDNA Origin] Protamine Suspension and 30% Insulin Aspart [rDNA Origin]) Injection)
Company:  Novo Nordisk Pharmaceuticals, Inc.
Application No.:  21-172
Approval Date: 11/1/2001


Date created: August 29, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.